drugset / Trial / NCT05822713
A Comparison of the Efficacy of Amisulpride and Placebo in the Prevention of PONV in Patients at Moderate-to-high Risk of PONV.
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A comparison of the efficacy of Amisulpride and placebo in the prevention of PONV in patients at moderate-to-high risk of PONV.
Timeline
- Start
- 2023-04-29
- Primary completion
- 2023-08-31
- Completion
- 2023-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amisulpride | Small molecule | 5 mg | Intravenous |
Indications
No indication recorded.